Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers.

JID Innov · 2023 · PMC10507651 · PMID 37731472

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Whereas calcipotriol treatment alone showed a trend toward reduced breast tumor growth, IMQ monotherapy did not have any impact on breast tumor growth after the three applications ( Figure 1 d).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.